Controversies in Screening Mammography.
The utility and effectiveness of screening mammography in diagnosing breast cancer at earlier stages and reducing disease-specific mortality remain controversial especially as to when to start and stop routine mammographic screening, and whether mammograms should be performed annually or biennially in average-risk women. This manuscript will analyze the available moderate and high-quality data to analyze both the benefits (lives saved and life-years saved) and inconveniences/harms (additional views, extra biopsies/overdiagnosis, and overtreatment of ductal carcinoma in situ) of different mammography screening guidelines to assist the practitioner in counseling their patients in clinical practice.
*Henry Ford Health System, Women's Health Services-Breast Diseases †University of Michigan, Detroit, Michigan.
Monique
M
Swain
Myrlene
M
Jeudy
Mark D
MD
Pearlman
D001943:Breast Neoplasms / Q000000981:diagnostic imaging* / Q000401:mortality / Q000473:pathology / Q000628:therapy; D002285:Carcinoma, Intraductal, Noninfiltrating / Q000000981:diagnostic imaging* / Q000473:pathology / Q000628:therapy; D055088:Early Detection of Cancer; D005189:False Positive Reactions; D005260:Female; D006801:Humans; D008327:Mammography / Q000009:adverse effects; D000069342:Medical Overuse; D010146:Pain / Q000209:etiology; D017410:Practice Guidelines as Topic; D011829:Radiation Dosage; D016032:Randomized Controlled Trials as Topic